[1]
Fatihoglu, S.G. and Oto, A. 2024. Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Clinical Benefits and Antiarrhythmic Actions. Advances in Cardiac Research. 2, 1 (May 2024), 12–25. DOI:https://doi.org/10.5281/zenodo.14572251.